LRRC59 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.064600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.322000E-01
Normal-vs-Stage2
1.720210E-01
Normal-vs-Stage3
5.658000E-01
Normal-vs-Stage4
7.129600E-02
Stage1-vs-Stage2
2.546600E-01
Stage1-vs-Stage3
8.946000E-01
Stage1-vs-Stage4
2.064200E-01
Stage2-vs-Stage3
4.325000E-01
Stage2-vs-Stage4
8.423600E-01
Stage3-vs-Stage4
3.926000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.303200E-01
Normal-vs-AfricanAmerican
8.742300E-02
Normal-vs-Asian
2.295600E-01
Caucasian-vs-AfricanAmerican
5.087400E-01
Caucasian-vs-Asian
8.310600E-01
AfricanAmerican-vs-Asian
4.022800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.551600E-01
Normal-vs-Female
1.540830E-01
Male-vs-Female
8.729600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.555200E-01
Normal-vs-Age(41-60Yrs)
1.178760E-01
Normal-vs-Age(61-80Yrs)
2.592200E-01
Normal-vs-Age(81-100Yrs)
2.163400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.076770E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.372000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.989170E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.693500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.813900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.822600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.995380E-01
Normal-vs-Daily Drinker
5.471600E-01
Normal-vs-Weekly Drinker
7.750200E-02
Normal-vs-Occasional Drinker
2.020200E-01
Normal-vs-Social Drinker
1.868580E-01
Non Drinker-vs-Daily Drinker
7.953500E-02
Non Drinker-vs-Weekly Drinker
1.251400E-01
Non Drinker-vs-Occasional Drinker
1.481580E-01
Non Drinker-vs-Social Drinker
1.274580E-01
Daily Drinker-vs-Weekly Drinker
4.239000E-03
Daily Drinker-vs-Occasional Drinker
2.169800E-02
Daily Drinker-vs-Social Drinker
2.485500E-02
Weekly Drinker-vs-Occasional Drinker
7.224200E-01
Weekly Drinker-vs-Social Drinker
5.543200E-01
Occasional Drinker-vs-Social Drinker
8.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.553400E-01
Normal-vs-Grade 2
8.800400E-01
Normal-vs-Grade 3
9.321800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.134000E-01
Grade 1-vs-Grade 3
7.979600E-01
Grade 1-vs-Grade 4
8.553400E-01
Grade 2-vs-Grade 3
2.973400E-01
Grade 2-vs-Grade 4
8.800400E-01
Grade 3-vs-Grade 4
9.321800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.796400E-01
Normal-vs-NonDiabetic
1.712820E-01
Diabetic-vs-NonDiabetic
1.324220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.524400E-02
Normal-vs-NoPancreatitis
2.140200E-01
Pancreatitis-vs-NoPancreatitis
8.567200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.128400E-01
Normal-vs-N1
1.824160E-01
N0-vs-N1
3.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.096400E-02
Normal-vs-TP53-NonMutant
3.673000E-01
TP53-Mutant-vs-TP53-NonMutant
1.246410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
